跳至主要内容
临床试验/NCT04451460
NCT04451460已完成不适用

Frequency and Effect on the Prognosis of Hyponatremia During the diagnosıs in Small Cell Lung Cancer

Ankara City Hospital Bilkent0 个研究点目标入组 466 人开始时间: 2012年1月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
466
主要终点
Mortality

研究概览

简要总结

In this retrospective study, the investigators determined the frequency of hyponatremia in small cell lung cancer and the prognosis. 126 (27%) of 466 patients were hyponatremic. Hyponatremia could not be corrected in 50.8% (n=64) of hyponatremic patients. Survival was found to be better in the group of whom hyponatremia was corrected.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients diagnosed with SCLC between January 2012 and January 2017 in our hospital were retrospectively screened

排除标准

  • Over 18 age If data doesn't exist

结局指标

主要结局

Mortality

时间窗: Through study completion, an average of 3 months

Effect of hyponatremia according to mortality

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

相似试验